PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 23667771-1 2013 AIM: To study the possible interactions of metoclopramide, domperidone and erythromycin in streptozotocin-induced diabetic mice treated with insulin by various parameters. Erythromycin 75-87 insulin Homo sapiens 141-148 23667771-16 2013 The use of prokinetics, such as erythromycin, may be interesting in the clinic in decreasing the need for insulin in diabetic patients. Erythromycin 32-44 insulin Homo sapiens 106-113 23667771-17 2013 The dose of insulin may be safely decreased with erythromycin in chronic treatments. Erythromycin 49-61 insulin Homo sapiens 12-19 23667771-10 2013 Erythromycin tended to decrease blood glucose level and increase serum insulin level after 1 wk of daily administration in diabetic mice. Erythromycin 0-12 insulin Homo sapiens 71-78 23667771-11 2013 Erythromycin potentiated the effect of insulin on blood glucose level and serum insulin level whereas other prokinetic agents failed to do so after repeated dose administration in diabetic mice. Erythromycin 0-12 insulin Homo sapiens 39-46 23667771-11 2013 Erythromycin potentiated the effect of insulin on blood glucose level and serum insulin level whereas other prokinetic agents failed to do so after repeated dose administration in diabetic mice. Erythromycin 0-12 insulin Homo sapiens 80-87 10819233-9 2000 Erythromycin infusion significantly increased plasma insulin and decreased glucose concentrations in Type II diabetic and control subjects and greatly potentiated glucose-induced insulin secretion in the latter (third study). Erythromycin 0-12 insulin Homo sapiens 53-60 15983224-14 2005 However, when erythromycin was added to GLP-1, insulin concentrations were similar to those in placebo experiments. Erythromycin 14-26 insulin Homo sapiens 47-54 9203450-0 1997 Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis. Erythromycin 0-12 insulin Homo sapiens 54-61 9203450-5 1997 CONCLUSIONS: Preliminary results obtained from a small number of patients suggest that EM523L or erythromycin analogs, which have agonistic activity to motilin receptors as well as no antibacterial effect, may be useful to accelerate gastric emptying and improve insulin requirement patterns, thereby establishing more stable glycemic control. Erythromycin 97-109 insulin Homo sapiens 263-270